Tom Brady Clones His Beloved Dog Lua

In-Depth Analysis

Tom Brady's decision to clone his dog Lua showcases the advancements in biotechnology and its increasing application in personal life. Colossal Biosciences, known for its 'de-extinction' efforts, including bringing back the dire wolf and the dodo bird, has now ventured into pet cloning with the acquisition of Viagen Pets and Equine. This move positions Colossal as a key player in both de-extinction and pet cloning markets. The cloning process involved using a blood sample collected from Lua before her death in 2023. The resulting dog, Junie, is genetically identical to Lua, offering Brady and his family a 'second chance' with a beloved pet. This news arrives as the technologies become more mainstream, raising questions about accessibility and ethics around bringing back animals from the dead, or cloning new ones. The technology has been used on pets of celebrities like Barbra Streisand and Paris Hilton, pointing to the growing popularity of the technology.

Read source article

FAQ

How was Lua cloned?

Lua was cloned using a blood sample collected prior to her death, through Colossal Biosciences.

What is Colossal Biosciences known for?

Colossal Biosciences is known for its de-extinction efforts, such as trying to bring back the dire wolf and the dodo bird.

Takeaways

Pet cloning technology is becoming more accessible, offering a way to replicate beloved pets.
Companies like Colossal Biosciences are expanding their focus from de-extinction to pet cloning.
Ethical considerations surrounding pet cloning and de-extinction continue to be a topic of debate.

Discussion

What are your thoughts on pet cloning? Share this article with others who need to stay ahead of this trend!

Sources

Tom Brady Reveals His Dog Junie Was Cloned from Beloved Pet Lua, Who Died in 2023 Tom Brady reveals he cloned his late dog Lua who died in 2023 Tom Brady Says His Dog Junie Is Clone of Former Dog Lua That Died in 2023

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.